Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
Sponsored Content
Results:
Three Reasons Acoustic Neuroma Patients Need a Multidisciplinary Care Team
**Sponsored Content**
An acoustic neuroma diagnosis comes with complex treatment decisions. Read why a multidisciplinary care team is crucial for your long-term recovery.
Coping with a GBM Diagnosis: Developing a Routine
**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
Neurosurgeon Brings One-of-a-Kind Imaging Technology to Puerto Rico to Advance Brain Tumor Surgery
**Sponsored Content** Meet one neurosurgeon who hopes to transform brain tumor care by bringing state-of-the-art technology to his homeland of Puerto Rico.
What You Should Know About Clinical Trials for Brain Tumors
**Sponsored Content** Advancements in brain tumor treatments are made possible by patients who volunteer to participate in clinical trials.
A Targeted Solution in Glioblastoma Treatment
**Sponsored Content**
For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.
Clinical Advances in GBM
**Sponsored Content**
See how a cutting-edge imaging solution by Medexus Pharma is revolutionizing treatment outcomes for GBM patients.
Pacific Neuroscience Institute’s Top Brain Surgeons Attract Patients from Around the World
**Sponsored Content**
Chris traveled across the country for a minimally invasive “keyhole” procedure to remove his large meningioma. Read why he chose Dr. Daniel Kelly at Pacific Neuroscience Institute (PNI) for his brain surgery.
From Testing to Treatment: What to Know About Targeted Therapies
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
